The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis)
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
The therapy is mutation-agnostic and aims to overcome limitations of existing EGFR-targeting drugs by concentrating degradation in tumors while sparing healthy tissue
Siponimod Tablets is indicated for the treatment of relapsing forms of multiple sclerosis
The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
Everolimus is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients in kidney and liver transplantation
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
Maria Soler Nunez appointed as Chief Quality Officer
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
